Nisa Investment Advisors
GBT

Nisa Investment Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Nisa Investment Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,110
Closed -$67K – 2666
2022
Q2 		$67K Buy
2,110
+600
+40% +$17.6K ﹤0.01% 1636
2022
Q1 		$52K Buy
1,510
+650
+76% +$19.4K ﹤0.01% 1832
2021
Q4 		$25K Hold
860
– – ﹤0.01% 1888
2021
Q3 		$22 Sell
860
-1,350
-61% -$39.7K ﹤0.01% 2079
2021
Q2 		$77 Sell
2,210
-2,360
-52% -$92.1K ﹤0.01% 1815
2021
Q1 		$186 Buy
4,570
+1,100
+32% +$50.6K ﹤0.01% 1514
2020
Q4 		$150K Sell
3,470
-1,100
-24% -$54.2K ﹤0.01% 1586
2020
Q3 		$252K Buy
4,570
+1,100
+32% +$69.9K ﹤0.01% 1251
2020
Q2 		$219K Sell
3,470
-2,405
-41% -$165K ﹤0.01% 1262
2020
Q1 		$300K Sell
5,875
-140
-2% -$9.38K ﹤0.01% 1082
2019
Q4 		$478K Sell
6,015
-4,660
-44% -$276K ﹤0.01% 1110
2019
Q3 		$518K Buy
10,675
+2,130
+25% +$111K ﹤0.01% 1080
2019
Q2 		$449K Hold
8,545
– – ﹤0.01% 1110
2019
Q1 		$452K Hold
8,545
– – ﹤0.01% 1092
2018
Q4 		$351K Buy
8,545
+3,300
+63% +$124K ﹤0.01% 1105
2018
Q3 		$199K Buy
5,245
+70
+1% +$3.1K ﹤0.01% 1322
2018
Q2 		$234K Hold
5,175
– – ﹤0.01% 1235
2018
Q1 		$302K Sell
5,175
-175
-3% -$9.76K ﹤0.01% 1150
2017
Q4 		$211K Hold
5,350
– – ﹤0.01% 1263
2017
Q3 		$166K Hold
5,350
– – ﹤0.01% 1295
2017
Q2 		$145K Sell
5,350
-6,560
-55% -$195K ﹤0.01% 1297
2017
Q1 		$439K Buy
11,910
+11,510
+2,878% +$290K 0.01% 1073
2016
Q4 		$6K Buy
+400
New +$7.03K ﹤0.01% 1845

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nisa Investment Advisors's GBT Position: Q3 2022 in Review

Nisa Investment Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 2,110 shares — an estimated $67K sold.

Nisa Investment Advisors first reported a position in GBT in Q4 2016 and held it in 23 quarters. The position peaked at $518K in Q3 2019. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Nisa Investment Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Nisa Investment Advisors sold 2,110 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $67K.
  • Nisa Investment Advisors first reported a position in Global Blood Therapeutics, Inc. in Q4 2016 and held it in 23 quarters.
  • Nisa Investment Advisors's Global Blood Therapeutics, Inc. position peaked at $518K in Q3 2019.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Nisa Investment Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.